Instituto Carlos Chagas, founded in 1965, is a leading innovator in the healthcare industry in East Minas Gerais, offering vaccines, laboratory tests, and customer-centric services. With over 150 dedicated employees, 16 units, and an NPS of 94, the company continues to expand its presence in the region. The incorporation of vaccines and anatomical pathology into their portfolio, along with the recent acquisition of the renowned Laboratório Cabral Ruback in 2024, has significantly strengthened their foothold in the Vale do Aço region, with collection points in Timóteo, Coronel Fabriciano, and surrounding areas. Instituto Carlos Chagas is committed to continuous investment in technology and training to provide a unique laboratory experience to its clients and partners. The company's strong trajectory and strategic expansions position it as a promising investment opportunity in the evolving healthcare sector. Stay tuned for their latest developments on social media channels. @carloschagasgv
There is no investment information